The University of Southampton is a public research university in Southampton, England. Southampton is a founding member of the Russell Group of research-intensive universities in the United Kingdom, and ranked in the top 100 universities in the world. The university has seven campuses.

During the past decade, University of Southampton conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 4 clinical trials were completed, i.e. on average, 23.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Southampton" #1 sponsor was "University of Southampton" with 17 trials, followed by "University Hospital Southampton NHS Foundation Trust" with 2 trials sponsored, "Bavarian Nordic" with 1 trials sponsored, "Hazel Everitt" with 1 trials sponsored and "Incyte Corporation" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Southampton" #1 collaborator was "National Institute for Health Research, United Kingdom" with 6 trials as a collaborator, "University of Southampton" with 4 trials as a collaborator, "Great Ormond Street Hospital for Children NHS Foundation Trust" with 2 trials as a collaborator, "Solent NHS Trust" with 2 trials as a collaborator and "University Hospital Southampton NHS Foundation Trust" with 2 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "University of Southampton" are "Parkinson Disease" (3 trials), "Asthma" (2 trials), "COPD" (2 trials), "Chronic Pain" (2 trials) and "(Focus) Posture Effect on Cognitive Performance" (1 trials). Many other conditions were trialed in "University of Southampton" in a lesser frequency.

Most popular intervention types in "University of Southampton" are "Other" (11 trials), "Behavioral" (5 trials), "Drug" (5 trials), "Dietary Supplement" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "At Risk Case Clinics" (1 trials), "Attentional bias modification training (AMG)" (1 trials), "Attentional bias placebo (ACG)" (1 trials) and "Best Standard Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Southampton" are 21 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Southampton". 1 are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in University of Southampton, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Southampton, 4 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".

University of Southampton has several departments that took part in Clinical trials: "Southampton General Hospital; Somers Cancer Research Building" - 3 trials, "Southampton Clinical Trials Unit" - 2 trials, "Somers Cancer Research Building" - 2 trials, "Southampton University Hospital Division of Clinical Neurosciences" - 2 trials